BUILDING CAPACITY FOR CANCER CARE IN KENYA.
Cancer is projected to become the leading cause of death in sub-Saharan Africa, but as recently as a decade ago, there were no cancer treatment options available in western Kenya.
The AMPATH Oncology Institute was formed in 2008 to combat this trend, and has built a system of cancer treatment and prevention. In 2016, we opened the Chandria Cancer and Chronic Disease Centre at Moi Teaching and Referral Hospital in Kenya, which serves as a learning institute to train the next generation of Kenyan caregivers, and provides a home for robust research and care.
We’ve also assisted the Kenyan Ministry of Health in drafting the Kenya National Cancer Control Strategy, which helps formulate national health policies, solutions to current national health problems, and plans for health professional training.
Cancer patients treated in 2018
Oncology doctors, nurses and physician extenders trained
Clinical sites with established cancer treatment and care
AREAS OF FOCUS
More women in Kenya are lost to cervical cancer than any other cancer. That’s why it’s a key focus of our work in cancer care, along with breast cancer. We’ve set up screening clinics locally that screened approximately 60,000 Kenyan women for cervical and breast cancers over the past five years. And we’re working to improve education about the importance of screening, follow-up, and prevention, not just for cancer but for the strongly linked Human Papillomavirus (HPV).
For patients with hematological conditions such as sickle cell disease, hemophilia, and multiple myeloma, follow-up care and regular access to treatment is critical. That’s why AMPATH has established three rural outreach clinics for hematology patients to be seen on a weekly basis, and we’ve been able to host daily clinics at the AMPATH Center.Additionally, we are supporting five county hospital to conduct screenings, educate medical personnel, and conduct research. Together with the Indiana Hemophilia and Thrombosis Center, we’re also training doctors and healthcare professionals in hematology as part of our exchange programs.
Before 2007, no treatment for pediatric cancer existed in Western Kenya. In 2010, AMPATH began oncology training opportunities for doctors, students, nurses, and other health care providers to test, diagnose, and treat pediatric cancer through collaboration with VU University Medical Centre in the Netherlands and Riley Children’s Hospital, Indiana University in the US. Childhood cancers must be aggressively treated early and effectively in the first round to help kids survive. AMPATH Oncology has dramatically reduced the time in diagnosis for cancers like Burkitt Lymphoma, Acute Lymphoblastic leukemia, and Nephroblastoma among others, from multiple weeks to a few days.
The new Telemedicine and Telepathology Center at Moi Teaching and Referral Hospital is making a difference in remote areas of western Kenya by bringing medical care virtually to communities. Patients and families can now save on transportation costs and time that come with travel to clinics or the hospital. Fully trained oncology professionals and experts at the Center can now connect remotely with rural clinics and care for patients who might not otherwise have had access to cancer care. The Center also allows both local and international oncology specialists to conduct lectures, consultation and patient case reviews virtually, helping share knowledge from across our partnerships.
AMPATH Oncology is educating the next generation of cancer healthcare providers by providing extensive resources, mentoring and training programs for medical students, residents, fellows, nurses and more. In 2017, a formal Preceptorship Program for oncology training was established by Prof. Fredrick Chite. The program provides resources for physicians continuing to build their skills and broadens opportunities for the highest-quality care across the continuum of prevention, treatment, palliative care, and survivorship. In addition to academic and clinical training, the program is developing a center of excellence and increasing oncology research capacity.
YOUR GIFT MAKES A DIFFERENCE.
Biopsy needle to diagnose a childhood cancer
Lab testing for leukemia and lymphoma to perform flow cytometry
Cervical cancer screening for 25 women
Complete treatment for a patient with curable non-Hodgkin’s lymphoma